Pancreastatin and its 33–49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo
- 1 July 1992
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 23 (4) , 637-638
- https://doi.org/10.1016/0306-3623(92)90140-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Glycogenolytic effect of pancreastatin in the ratBioscience Reports, 1990
- Effects of Porcine Pancreastatin on Secretion and Biosynthesis of Insulin and Glucose Oxidation of Isolated Rat Pancreatic IsletsPancreas, 1989
- Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreasMetabolism, 1989
- Inhibition of Glucose-Stimulated Insulin Release in the Perfused Rat Pancreas by Parathyroid Secretory Protein-I (Chromogranin-A)*Endocrinology, 1989
- Effect of pancreastatin on pancreatic endocrine function in the conscious ratRegulatory Peptides, 1989
- Pancreastatin inhibits insulin release from Rin m 5F cells: reversion by pertussis toxinEuropean Journal of Pharmacology, 1989
- Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreasLife Sciences, 1988
- Pancreastatin, a novel pancreatic peptide that inhibits insulin secretionNature, 1986
- Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissuesNature, 1986
- Regulation of Adenosine 3′,5′-Monophosphate Levels in the Pancreatic B Cell*Endocrinology, 1985